Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
allogeneic Myeloma GM-CSF Vaccine / Sidney Kimmel Comprehensive Cancer Center
NCT03376477: Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission	Active, not recruiting	2	54	US	GM-CSF vaccine, GVAX, Lenalidomide, Revlimid, Prevnar13, pneumococcal vaccine, Placebo Prevnar13, Placebo GM-CSF Vaccine	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Celgene, Aduro Biotech, Inc.	Multiple Myeloma	01/24	12/24